<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 11pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<P STYLE="font: 18pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>UNITED STATES</B></P>

<P STYLE="font: 18pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>SECURITIES AND EXCHANGE COMMISSION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Washington, D.C.&nbsp;20549</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 18pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>FORM 8-K</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>CURRENT REPORT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Pursuant to Section 13 or 15(d) of the Securities
Exchange Act of 1934</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">Date of Report&nbsp;(Date of Earliest Event
Reported):&nbsp;<B>&nbsp;January 26, 2012</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 18pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>CNS RESPONSE, INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">(Exact name of Company as specified in its charter)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 32%; padding-right: 0.8pt; line-height: 115%; font-weight: bold; text-align: center"><B>Delaware</B></TD>
    <TD STYLE="width: 36%; padding-right: 0.8pt; line-height: 115%; font-weight: bold; text-align: center"><B>0-26285</B></TD>
    <TD STYLE="width: 32%; padding-right: 0.8pt; line-height: 115%; font-weight: bold; text-align: center"><B>87-0419387</B></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0.8pt; line-height: 115%; text-align: center">(State or other</TD>
    <TD STYLE="padding-right: 0.8pt; line-height: 115%; text-align: center">(Commission File No.)</TD>
    <TD STYLE="padding-right: 0.8pt; line-height: 115%; text-align: center">(I.R.S. Employer</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0.8pt; line-height: 115%; text-align: center">&nbsp;jurisdiction of</TD>
    <TD STYLE="padding-right: 0.8pt; line-height: 115%">&nbsp;</TD>
    <TD STYLE="padding-right: 0.8pt; line-height: 115%; text-align: center">Identification No.)</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0.8pt; line-height: 115%; text-align: center">incorporation)</TD>
    <TD STYLE="padding-right: 0.8pt; line-height: 115%">&nbsp;</TD>
    <TD STYLE="padding-right: 0.8pt; line-height: 115%">&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>85 Enterprise, Suite 410</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Aliso Viejo, CA&nbsp;92656</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">(Address of principal executive offices)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>(714) 545-3288</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">(Registrant&rsquo;s telephone number, including
area code)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Not Applicable</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">(Former name or former address, if changed since
last report)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="background-color: white">
    <TD STYLE="width: 5%; padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font-family: Wingdings 2">&#163;</FONT></TD>
    <TD STYLE="width: 95%; padding-right: 0.8pt; line-height: 115%">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="background-color: white">
    <TD STYLE="width: 5%; padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font-family: Wingdings 2">&#163;</FONT></TD>
    <TD STYLE="width: 95%; padding-right: 0.8pt; line-height: 115%">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="background-color: white">
    <TD STYLE="width: 5%; padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font-family: Wingdings 2">&#163;</FONT></TD>
    <TD STYLE="width: 95%; padding-right: 0.8pt; line-height: 115%">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="background-color: white">
    <TD STYLE="width: 5%; padding-right: 0.8pt; line-height: 115%"><FONT STYLE="font-family: Wingdings 2">&#163;</FONT></TD>
    <TD STYLE="width: 95%; padding-right: 0.8pt; line-height: 115%">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>Item 1.01&nbsp;Entry into a Material Definitive Agreement.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">The description of the Bridge Financing Purchase Agreement (as defined
below) is incorporated by reference to Item 2.03 hereof.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>Item 2.03&nbsp;Creation of a Direct Financial Obligation&nbsp;or
an Obligation under an Off-Balance Sheet Arrangement of a Registrant.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On November 11, 2011, CNS Response, Inc. (the
&ldquo;Company&rdquo;) entered into an Amended and Restated Note and Warrant Purchase Agreement (the &ldquo;Bridge Financing Purchase
Agreement&rdquo;) in connection with a $2 million bridge financing (the &ldquo;Bridge Financing&rdquo;) with accredited investors.&nbsp;&nbsp;Pursuant
to the agreement, the Company, between January 26, 2012 and January 30, 2012, issued subordinated secured convertible notes (the
&ldquo;Bridge Notes&rdquo;) in the aggregate principal amount of $740,000 and warrants to purchase 7,400,000 shares of common stock
to five accredited investors. One of these notes for an aggregate principal amount of $40,000 and warrants to purchase 400,000
shares of common stock were issued to an entity affiliated with Zachary McAdoo, who is a member of the Company&rsquo;s Board of
Directors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Bridge Financing Purchase Agreement provides
for the issuance and sale of Bridge Notes in the aggregate principal amount of up to $2,000,000, and warrants to purchase a number
of shares corresponding to 100% of the number of shares issuable on conversion of the Bridge Notes, in one or multiple closings
to occur no later than April 1, 2012.&nbsp;&nbsp;The Company had previously issued Bridge Notes pursuant to the Bridge Financing
Purchase Agreement in the aggregate principal amount of $1,260,000 and related warrants to purchase 12,600,000 shares of common
stock. Together with the January 26 through January 30 issuances, the Company has now issued Bridge Notes in the aggregate principal
amount of $2,000,000 and related warrants to purchase 20,000,000 shares of common stock pursuant to the Bridge Financing Purchase
Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The descriptions of the Bridge Notes and related
warrants, the Bridge Financing Purchase Agreement and the Amended and Restated Security Agreement governing the second position
security interest applicable to the Bridge Notes, are incorporated by reference to Item 2.03 in the Company&rsquo;s Current Report
on Form 8-K filed on November 17, 2011.&nbsp;&nbsp;Such descriptions do not purport to be complete and are qualified in their entirety
by reference to the full text of those documents.&nbsp;&nbsp;The form of Bridge Note is incorporated by reference to Exhibit 10.58
to the Company&rsquo;s Annual Report on Form 10-K for the year ended September 30, 2011 filed on December 22, 2011 (the &ldquo;2011
10-K&rdquo;).&nbsp;&nbsp;The form of warrant is incorporated by reference to Exhibit 4.2 to the Company&rsquo;s Current Report
on Form 8-K filed on October 24, 2011 (the &ldquo;October 8-K&rdquo;).&nbsp;&nbsp;The form of Bridge Financing Purchase Agreement
is incorporated by reference to Exhibit 10.56.1 to the 2011 10-K. The Amended and Restated Security Agreement is incorporated by
reference to Exhibit 10.2 to the October 8-K.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>Item 3.02&nbsp;Unregistered Sales of Equity Securities.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">The description of the Bridge Notes and the related warrants is
incorporated herein by reference to Item 2.03.&nbsp;&nbsp;&nbsp;The Bridge Notes and Bridge Note warrants were issued by the Company
under the exemption from registration afforded by Section 4(2) of the Securities Act of 1933, as amended, and Regulation D promulgated
thereunder, as they were issued to accredited investors, without a view to distribution, and were not issued through any general
solicitation or advertisement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0.8pt 0 0"><B>Item&nbsp;5.07</B> <B>Submission of Matters to a Vote
of Security Holders.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0">At the special meeting of stockholders of CNS
Response, Inc. (&ldquo;the Company&rdquo;), held on January 27, 2012, 35,374,880 shares of common stock were voted, representing
62.92% of the outstanding shares.&nbsp;&nbsp;The Company&rsquo;s stockholders voted (by a vote of 35,304,855 to 25,025, with 45,000
votes abstaining and 0 broker non-votes ) to approve the amendment of the Company&rsquo;s Certificate of Incorporation for the
purposes of effecting a reverse stock split of common stock at a specific ratio within a range from 1 for 10 to 1 for 50 and simultaneously
with the reverse split, reducing the number of authorized shares of common stock available for issuance from 750,000,000 to 100,000,000,
and to authorize the Company&rsquo;s Board of Directors to determine, at its discretion, the timing of the amendment and the specific
ratio of the reverse stock split. The Company&rsquo;s stockholders also voted (by a vote of 35,312,228 to 23, with 62,629 votes
abstaining and 0 broker non-votes ) to ratify the selection of Cacciamatta Accountancy Corporation as the independent registered
public accounting firm of the Company for the fiscal year ending September 30, 2012.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>SIGNATURES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.75in">Pursuant to the Securities Exchange Act of
1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.75in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0.8pt; line-height: 115%">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="padding-right: 1.8pt; line-height: 115%">CNS Response, Inc.</TD>
    <TD STYLE="padding-right: 0.8pt; line-height: 115%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0.8pt; line-height: 115%">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="padding-right: 1.8pt; line-height: 115%">&nbsp;</TD>
    <TD STYLE="padding-right: 0.8pt; line-height: 115%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 51%; padding-right: 0.8pt; line-height: 115%">&nbsp;</TD>
    <TD STYLE="width: 3%; padding-right: 0.8pt; line-height: 115%">By:</TD>
    <TD STYLE="width: 34%; border-bottom: black 1.5pt solid; padding-right: 0.8pt; line-height: 115%">/s/ Paul Buck</TD>
    <TD STYLE="width: 12%; padding-right: 0.8pt; line-height: 115%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0.8pt; line-height: 115%">January 31, 2012</TD>
    <TD STYLE="padding-right: 0.8pt; line-height: 115%">&nbsp;</TD>
    <TD STYLE="padding-right: 0.8pt; line-height: 115%">Paul Buck</TD>
    <TD STYLE="padding-right: 0.8pt; line-height: 115%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0.8pt; line-height: 115%">&nbsp;</TD>
    <TD STYLE="padding-right: 0.8pt; line-height: 115%">&nbsp;</TD>
    <TD STYLE="padding-right: 0.8pt; line-height: 115%; font-style: italic"><I>Chief Financial Officer</I></TD>
    <TD STYLE="padding-right: 0.8pt; line-height: 115%">&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>



<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 3; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->
<P STYLE="margin: 0"></P>

</BODY>
</HTML>
[{"type": "8-K", "sequence": "1", "filename": "v300842_8k.htm", "description": "FORM 8-K", "secsgml_size_bytes": 17930}]
{"company-data": {"conformed-name": "CNS RESPONSE, INC.", "cik": "0000822370", "assigned-sic": "8090", "irs-number": "870419387", "state-of-incorporation": "DE", "fiscal-year-end": "0930"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "000-26285", "film-number": "12558622"}, "business-address": {"street1": "85 ENTERPRISE", "street2": "SUITE 410,", "city": "ALISO VIEJO", "state": "CA", "zip": "92656", "phone": "(714) 545 3288"}, "mail-address": {"street1": "85 ENTERPRISE", "street2": "SUITE 410,", "city": "ALISO VIEJO", "state": "CA", "zip": "92656"}, "former-company": [{"former-conformed-name": "STRATIVATION, INC.", "date-changed": "20051115"}, {"former-conformed-name": "SalesTactix, Inc.", "date-changed": "20040805"}, {"former-conformed-name": "AGE RESEARCH INC", "date-changed": "19990210"}]}
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities
Exchange Act of 1934
Date of Report (Date of Earliest Event
Reported):
January 26, 2012
CNS RESPONSE, INC.
(Exact name of Company as specified in its charter)
Delaware
0-26285
87-0419387
(State or other
(Commission File No.)
(I.R.S. Employer
jurisdiction of
Identification No.)
incorporation)
85 Enterprise, Suite 410
Aliso Viejo, CA 92656
(Address of principal executive offices)
(714) 545-3288
(Registrant's telephone number, including
area code)
Not Applicable
(Former name or former address, if changed since
last report)
Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
£
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
£
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
£
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
£
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 1.01 Entry into a Material Definitive Agreement.
The description of the Bridge Financing Purchase Agreement (as defined
below) is incorporated by reference to Item 2.03 hereof.
Item 2.03 Creation of a Direct Financial Obligation or
an Obligation under an Off-Balance Sheet Arrangement of a Registrant.
On November 11, 2011, CNS Response, Inc. (the
"Company") entered into an Amended and Restated Note and Warrant Purchase Agreement (the "Bridge Financing Purchase
Agreement") in connection with a $2 million bridge financing (the "Bridge Financing") with accredited investors.  Pursuant
to the agreement, the Company, between January 26, 2012 and January 30, 2012, issued subordinated secured convertible notes (the
"Bridge Notes") in the aggregate principal amount of $740,000 and warrants to purchase 7,400,000 shares of common stock
to five accredited investors. One of these notes for an aggregate principal amount of $40,000 and warrants to purchase 400,000
shares of common stock were issued to an entity affiliated with Zachary McAdoo, who is a member of the Company's Board of
Directors.
The Bridge Financing Purchase Agreement provides
for the issuance and sale of Bridge Notes in the aggregate principal amount of up to $2,000,000, and warrants to purchase a number
of shares corresponding to 100% of the number of shares issuable on conversion of the Bridge Notes, in one or multiple closings
to occur no later than April 1, 2012.  The Company had previously issued Bridge Notes pursuant to the Bridge Financing
Purchase Agreement in the aggregate principal amount of $1,260,000 and related warrants to purchase 12,600,000 shares of common
stock. Together with the January 26 through January 30 issuances, the Company has now issued Bridge Notes in the aggregate principal
amount of $2,000,000 and related warrants to purchase 20,000,000 shares of common stock pursuant to the Bridge Financing Purchase
Agreement.
The descriptions of the Bridge Notes and related
warrants, the Bridge Financing Purchase Agreement and the Amended and Restated Security Agreement governing the second position
security interest applicable to the Bridge Notes, are incorporated by reference to Item 2.03 in the Company's Current Report
on Form 8-K filed on November 17, 2011.  Such descriptions do not purport to be complete and are qualified in their entirety
by reference to the full text of those documents.  The form of Bridge Note is incorporated by reference to Exhibit 10.58
to the Company's Annual Report on Form 10-K for the year ended September 30, 2011 filed on December 22, 2011 (the "2011
10-K").  The form of warrant is incorporated by reference to Exhibit 4.2 to the Company's Current Report
on Form 8-K filed on October 24, 2011 (the "October 8-K").  The form of Bridge Financing Purchase Agreement
is incorporated by reference to Exhibit 10.56.1 to the 2011 10-K. The Amended and Restated Security Agreement is incorporated by
reference to Exhibit 10.2 to the October 8-K.
Item 3.02 Unregistered Sales of Equity Securities.
The description of the Bridge Notes and the related warrants is
incorporated herein by reference to Item 2.03.   The Bridge Notes and Bridge Note warrants were issued by the Company
under the exemption from registration afforded by Section 4(2) of the Securities Act of 1933, as amended, and Regulation D promulgated
thereunder, as they were issued to accredited investors, without a view to distribution, and were not issued through any general
solicitation or advertisement.
Item 5.07
Submission of Matters to a Vote
of Security Holders.
At the special meeting of stockholders of CNS
Response, Inc. ("the Company"), held on January 27, 2012, 35,374,880 shares of common stock were voted, representing
62.92% of the outstanding shares.  The Company's stockholders voted (by a vote of 35,304,855 to 25,025, with 45,000
votes abstaining and 0 broker non-votes ) to approve the amendment of the Company's Certificate of Incorporation for the
purposes of effecting a reverse stock split of common stock at a specific ratio within a range from 1 for 10 to 1 for 50 and simultaneously
with the reverse split, reducing the number of authorized shares of common stock available for issuance from 750,000,000 to 100,000,000,
and to authorize the Company's Board of Directors to determine, at its discretion, the timing of the amendment and the specific
ratio of the reverse stock split. The Company's stockholders also voted (by a vote of 35,312,228 to 23, with 62,629 votes
abstaining and 0 broker non-votes ) to ratify the selection of Cacciamatta Accountancy Corporation as the independent registered
public accounting firm of the Company for the fiscal year ending September 30, 2012.
SIGNATURES
Pursuant to the Securities Exchange Act of
1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
CNS Response, Inc.
By:
/s/ Paul Buck
January 31, 2012
Paul Buck
Chief Financial Officer